Skip to content

A multicenter confirmation clinical trial of untact upper extremity rehabilitation using smart board for late subacute and chronic patients with brain disorde

A multicenter confirmation clinical trial of untact upper extremity rehabilitation using smart board for late subacute and chronic patients with brain disorder - a randomized single-blinded controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010354
Enrollment
40
Registered
2025-03-28
Start date
2025-03-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : [Experimental group] -home-based upper limb rehabilitation training using the Neofect Smart board -a total of 20 sessions of home-based upper limb rehabilitation training using the Sm

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients with neurological diseases aged 19 to 85 years old -Patients with hemiparesis lasting for more than 3 months due to neurological diseases (stroke, traumatic brain injury, brain tumor) and impaired upper limb function -Patients with shoulder flexor and adductor muscle strength of MRC grade 2 or higher -Patients with shoulder extensor and abductor spasticity of MAS grade 1+ or lower -Participants with sufficient cognitive function to understand the instructions from the researcher and the smart board, and to perform the tasks (K-MMSE =21)

Exclusion criteria

Exclusion criteria: -pre-existing significant neurogenic disorders -major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia -History of diseases that caused pain or muscle atrophy in the affected upper limb before the onset of the neurological disease, which interfered with rehabilitation -Severe spasticity of the affected upper limb (Modified Ashworth Scale score =3) -skin disorders or open wounds on the affected upper limb -Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb -severe pain that interferes with rehabilitation of the affected upper limb (Numeric Rating Scale > 6) -Inability to maintain a seated posture for more than 10 minutes, which is required for using the smart board -Significant visual impairment to the extent that the screen cannot be recognized when using the smart board

Design outcomes

Primary

MeasureTime frame
Fugl Meyer assessment scale

Secondary

MeasureTime frame
Action research arm test;Medical Research Council scale of muscle strength;Active Range of Motion ;Modified Ashworth Scale

Countries

Korea, Republic of

Contacts

Public ContactWon Hyuk Chang

Samsung Medical Center

wh.chang@samsung.com+82-2-3410-6068

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026